BIZ-ZYDUSCADILA-USFDA - Zydus gets FDA nod for seizure, migraine drug

Drug firm Zydus Cadila on Monday said it had received final approval from 

the U.S. health regulator to market topiramate extended release capsules, used 

in the treatment of seizures and migraine. The company has received approval 

from the U.S. Food and Drug Administration to market the drug in strengths 

of  25 mg, 50 mg and 100 mg, Zydus Cadila said in a BSE filing.

Source: THE HINDU-28th November,2017

http://www.thehindu.com/todays-paper/tp-business/biz-zyduscadila-usfda/article21012991.ece